Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Berkhout, Ben"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 101
Tytuł:
In-house ELISA protocols for capsid p24 detection of diverse HIV isolates.
Autorzy:
Molina MA; Department of Medical Microbiology, Laboratory of Experimental Virology, Amsterdam UMC, AMC Location, University of Amsterdam, Amsterdam, The Netherlands.
Vink M; Department of Medical Microbiology, Laboratory of Experimental Virology, Amsterdam UMC, AMC Location, University of Amsterdam, Amsterdam, The Netherlands.
Berkhout B; Department of Medical Microbiology, Laboratory of Experimental Virology, Amsterdam UMC, AMC Location, University of Amsterdam, Amsterdam, The Netherlands.
Herrera-Carrillo E; Department of Medical Microbiology, Laboratory of Experimental Virology, Amsterdam UMC, AMC Location, University of Amsterdam, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2023 Nov 17; Vol. 20 (1), pp. 269. Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*
HIV-1*
Humans ; Capsid/chemistry ; Reproducibility of Results ; Sensitivity and Specificity ; Enzyme-Linked Immunosorbent Assay/methods ; HIV Core Protein p24/analysis ; Capsid Proteins
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A CRISPR-Cas Cure for HIV/AIDS.
Autorzy:
Hussein M; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Molina MA; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Herrera-Carrillo E; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jan 13; Vol. 24 (2). Date of Electronic Publication: 2023 Jan 13.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Acquired Immunodeficiency Syndrome*/genetics
Acquired Immunodeficiency Syndrome*/therapy
HIV Infections*/genetics
HIV Infections*/therapy
Viruses*
Humans ; CRISPR-Cas Systems/genetics ; Gene Editing ; Antiviral Agents
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A highly virulent variant of HIV-1 circulating in the Netherlands.
Autorzy:
Wymant C; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Bezemer D; Stichting HIV Monitoring, Amsterdam, Netherlands.
Blanquart F; Centre for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, PSL Research University, Paris, France.; IAME, UMR 1137, INSERM, Université de Paris, Paris, France.
Ferretti L; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Gall A; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Hall M; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Golubchik T; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Bakker M; Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
Ong SH; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
Zhao L; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Bonsall D; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
de Cesare M; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
MacIntyre-Cockett G; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Abeler-Dörner L; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Albert J; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Bannert N; Division for HIV and Other Retroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Fellay J; School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Grabowski MK; Department of Pathology, John Hopkins University, Baltimore, MD, USA.
Gunsenheimer-Bartmeyer B; Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Günthard HF; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Kivelä P; Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland.
Kouyos RD; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Laeyendecker O; Division of Intramural Research, NIAID, NIH, Baltimore, MD, USA.
Meyer L; INSERM CESP U1018, Université Paris Saclay, APHP, Service de Santé Publique, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
Porter K; Institute for Global Health, University College London, London, UK.
Ristola M; Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland.
van Sighem A; Stichting HIV Monitoring, Amsterdam, Netherlands.
Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
Kellam P; Kymab Ltd., Cambridge, UK.; Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, UK.
Cornelissen M; Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.; Molecular Diagnostic Unit, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
Reiss P; Stichting HIV Monitoring, Amsterdam, Netherlands.; Department of Global Health, Amsterdam University Medical Centers, University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands.
Fraser C; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Pokaż więcej
Corporate Authors:
Netherlands ATHENA HIV Observational Cohort†
BEEHIVE Collaboration†
Źródło:
Science (New York, N.Y.) [Science] 2022 Feb 04; Vol. 375 (6580), pp. 540-545. Date of Electronic Publication: 2022 Feb 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections/*virology
HIV-1/*pathogenicity
Adult ; Anti-HIV Agents/therapeutic use ; CD4 Lymphocyte Count ; Evolution, Molecular ; Female ; Genome, Viral ; Genotype ; HIV Infections/drug therapy ; HIV Infections/immunology ; HIV Infections/transmission ; HIV-1/genetics ; HIV-1/physiology ; Humans ; Male ; Mutation ; Netherlands ; Phylogeny ; Viral Load ; Virulence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transient CRISPR-Cas Treatment Can Prevent Reactivation of HIV-1 Replication in a Latently Infected T-Cell Line.
Autorzy:
Liu Y; Amsterdam UMC, Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Jeeninga RE; Amsterdam UMC, Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Klaver B; Amsterdam UMC, Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Berkhout B; Amsterdam UMC, Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Das AT; Amsterdam UMC, Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, University of Amsterdam, 1105AZ Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Dec 08; Vol. 13 (12). Date of Electronic Publication: 2021 Dec 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
CRISPR-Cas Systems*
Virus Activation*
HIV Infections/*virology
HIV-1/*genetics
T-Lymphocytes/*virology
Cell Line ; DNA, Viral/genetics ; Gene Editing ; HIV-1/physiology ; Humans ; Lentivirus/genetics ; Lentivirus/physiology ; Proviruses/genetics ; Proviruses/physiology ; Transduction, Genetic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Splice of Life: Does RNA Processing Have a Role in HIV-1 Persistence?
Autorzy:
Pasternak AO; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Viruses [Viruses] 2021 Sep 02; Vol. 13 (9). Date of Electronic Publication: 2021 Sep 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Disease Reservoirs/*virology
HIV Infections/*genetics
HIV-1/*genetics
Persistent Infection/*genetics
RNA Splicing/*genetics
Anti-Retroviral Agents/therapeutic use ; HIV Infections/drug therapy ; HIV Infections/virology ; Virus Latency/genetics ; Virus Replication
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CRISPR therapy towards an HIV cure.
Autorzy:
Herrera-Carrillo E; Department of Medical Microbiology Laboratory of Experimental Virology Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, the Netherlands.
Gao Z; Department of Medical Microbiology Laboratory of Experimental Virology Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, the Netherlands.
Berkhout B; Department of Medical Microbiology Laboratory of Experimental Virology Amsterdam UMC, AMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy.
Pokaż więcej
Źródło:
Briefings in functional genomics [Brief Funct Genomics] 2020 May 20; Vol. 19 (3), pp. 201-208.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Clustered Regularly Interspaced Short Palindromic Repeats/*genetics
Gene Editing/*methods
HIV Infections/*genetics
Genetic Therapy/methods ; Humans ; Lentivirus/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs.
Autorzy:
Darcis G; Infectious Diseases Department, Liège University Hospital, 4000 Liège, Belgium.
Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Pasternak AO; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Viruses [Viruses] 2020 Apr 27; Vol. 12 (5). Date of Electronic Publication: 2020 Apr 27.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
HIV-1/*drug effects
Animals ; Antiretroviral Therapy, Highly Active ; HIV Infections/virology ; HIV-1/genetics ; HIV-1/physiology ; Humans ; Treatment Outcome ; Virus Latency/drug effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies.
Autorzy:
Darcis G; Laboratory of Experimental Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. .; Infectious Diseases Department, Liège University Hospital, 4000 Liege, Belgium. .
Das AT; Laboratory of Experimental Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. .
Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. b.berkhout@amc.uva.nl.
Pokaż więcej
Źródło:
Viruses [Viruses] 2018 Mar 29; Vol. 10 (4). Date of Electronic Publication: 2018 Mar 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
HIV Infections/*virology
HIV-1/*genetics
Animals ; Anti-HIV Agents/pharmacology ; Anti-HIV Agents/therapeutic use ; CRISPR-Cas Systems ; Gene Expression Regulation, Viral/drug effects ; Gene Targeting ; HIV Infections/therapy ; HIV-1/drug effects ; HIV-1/immunology ; Humans ; Proviruses/genetics ; Proviruses/immunology ; Virus Activation/drug effects ; Virus Activation/genetics ; Virus Latency/drug effects ; Virus Latency/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
What do we measure when we measure cell-associated HIV RNA.
Autorzy:
Pasternak AO; Laboratory of Experimental Virology, Department of Medical Microbiology, Academic Medical Center of the University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands. .
Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Academic Medical Center of the University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Retrovirology [Retrovirology] 2018 Jan 29; Vol. 15 (1), pp. 13. Date of Electronic Publication: 2018 Jan 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Virus Latency*
CD4-Positive T-Lymphocytes/*virology
HIV Infections/*virology
HIV-1/*genetics
RNA, Viral/*analysis
Anti-HIV Agents/therapeutic use ; DNA, Viral/analysis ; HIV Infections/drug therapy ; HIV-1/drug effects ; HIV-1/growth & development ; Humans ; Proviruses/genetics ; Proviruses/growth & development ; Virus Replication
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe.
Autorzy:
Blanquart F; Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.
Wymant C; Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Cornelissen M; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Gall A; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Bakker M; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Bezemer D; Stichting HIV Monitoring, Amsterdam, the Netherlands.
Hall M; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Hillebregt M; Stichting HIV Monitoring, Amsterdam, the Netherlands.
Ong SH; Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Albert J; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Bannert N; Division for HIV and other Retroviruses, Robert Koch Institute, Berlin, Germany.
Fellay J; School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Fransen K; HIV/STI reference laboratory, WHO collaborating centre, Institute of Tropical Medicine, Department of Clinical Science, Antwerpen, Belgium.
Gourlay AJ; Department of Infection and Population Health, University College London, London, United Kingdom.
Grabowski MK; Department of Epidemiology, John Hopkins University, Baltimore, Maryland, United States of America.
Gunsenheimer-Bartmeyer B; Department of Infectious Disease Epidemiology, Robert Koch-Institute, Berlin, Germany.
Günthard HF; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Kivelä P; Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland.
Kouyos R; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Laeyendecker O; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, Maryland, United States of America.
Liitsola K; Department of Health Security, National Institute for Health and Welfare, Helsinki, Finland.
Meyer L; INSERM CESP U1018, Université Paris Sud, Université Paris Saclay, APHP, Service de Santé Publique, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
Porter K; Department of Infection and Population Health, University College London, London, United Kingdom.
Ristola M; Department of Health Security, National Institute for Health and Welfare, Helsinki, Finland.
van Sighem A; Stichting HIV Monitoring, Amsterdam, the Netherlands.
Vanham G; Virology Unit, Immunovirology Research Pole, Biomedical Sciences Department, Institute of Tropical Medicine, Antwerpen, Belgium.
Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands.
Kellam P; Kymab Ltd, Cambridge, United Kingdom.; Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom.
Reiss P; Stichting HIV Monitoring, Amsterdam, the Netherlands.; Department of Global Health, Academic Medical Center, Amsterdam, the Netherlands.
Fraser C; Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom.; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Pokaż więcej
Corporate Authors:
BEEHIVE collaboration
Źródło:
PLoS biology [PLoS Biol] 2017 Jun 12; Vol. 15 (6), pp. e2001855. Date of Electronic Publication: 2017 Jun 12 (Print Publication: 2017).
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Genetic Variation*
Genome, Viral*
Models, Genetic*
HIV Infections/*microbiology
HIV Seropositivity/*microbiology
HIV-1/*genetics
Human Immunodeficiency Virus Proteins/*genetics
Adult ; Aged ; Cohort Studies ; Europe ; Evolution, Molecular ; Female ; Genome-Wide Association Study ; HIV Infections/blood ; HIV Seropositivity/blood ; HIV-1/growth & development ; HIV-1/isolation & purification ; HIV-1/pathogenicity ; Human Immunodeficiency Virus Proteins/blood ; Human Immunodeficiency Virus Proteins/metabolism ; Humans ; Male ; Middle Aged ; Phylogeny ; Registries ; Seroconversion ; Viral Load ; Virulence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Novel AgoshRNA molecules for silencing of the CCR5 co-receptor for HIV-1 infection.
Autorzy:
Herrera-Carrillo E; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 May 24; Vol. 12 (5), pp. e0177935. Date of Electronic Publication: 2017 May 24 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections/*therapy
HIV-1/*genetics
Leukocytes, Mononuclear/*virology
RNA, Small Interfering/*genetics
RNA, Small Interfering/*therapeutic use
Receptors, CCR5/*genetics
T-Lymphocytes/*virology
Cell Line ; Down-Regulation ; HEK293 Cells ; HIV Infections/pathology ; HIV Infections/virology ; HIV-1/pathogenicity ; Humans ; Leukocytes, Mononuclear/metabolism ; RNA Interference ; T-Lymphocytes/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Widespread hepatitis B virus genotype G (HBV-G) infection during the early years of the HIV epidemic in the Netherlands among men who have sex with men.
Autorzy:
Cornelissen M; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.
Zorgdrager F; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.
Bruisten SM; Public Health Laboratory, GGD Amsterdam, Cluster Infectious Diseases, Nieuwe Achtergracht 100, Amsterdam, 1018 WT, The Netherlands.
Bakker M; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.
Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.
van der Kuyl AC; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2016 Jun 10; Vol. 16, pp. 268. Date of Electronic Publication: 2016 Jun 10.
Typ publikacji:
Journal Article
MeSH Terms:
Epidemics*
Bisexuality/*statistics & numerical data
HIV Infections/*epidemiology
Hepatitis B/*epidemiology
Hepatitis B virus/*genetics
Homosexuality, Male/*statistics & numerical data
Adult ; Cohort Studies ; Coinfection/epidemiology ; Cross-Sectional Studies ; DNA, Viral/blood ; Female ; Genotype ; Hepatitis B/blood ; Hepatitis B/virology ; Hepatitis B Surface Antigens/blood ; Humans ; Male ; Netherlands/epidemiology ; Prevalence ; Real-Time Polymerase Chain Reaction ; Retrospective Studies ; Viral Load
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
CRISPR/Cas9: a double-edged sword when used to combat HIV infection.
Autorzy:
Liang C; McGill University AIDS Centre, Lady Davis Institute, Jewish General Hospital, Montreal, QC, H3T1E2, Canada. .; Departments of Medicine, Microbiology and Immunology, McGill University, Montreal, QC, H3A 2B4, Canada. .
Wainberg MA; McGill University AIDS Centre, Lady Davis Institute, Jewish General Hospital, Montreal, QC, H3T1E2, Canada.; Departments of Medicine, Microbiology and Immunology, McGill University, Montreal, QC, H3A 2B4, Canada.
Das AT; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.
Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Retrovirology [Retrovirology] 2016 May 27; Vol. 13 (1), pp. 37. Date of Electronic Publication: 2016 May 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Therapy*
CRISPR-Cas Systems/*genetics
HIV Infections/*therapy
Anti-HIV Agents/metabolism ; Anti-HIV Agents/pharmacology ; Drug Resistance, Viral ; HIV Infections/genetics ; HIV-1/genetics ; INDEL Mutation ; Models, Biological ; Proviruses/genetics ; Proviruses/metabolism ; Virus Latency/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
High Current CD4+ T Cell Count Predicts Suboptimal Adherence to Antiretroviral Therapy.
Autorzy:
Pasternak AO; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
de Bruin M; Health Psychology Group, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom.
Bakker M; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
Prins JM; Department of Internal Medicine, Division of Infectious Diseases, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Oct 15; Vol. 10 (10), pp. e0140791. Date of Electronic Publication: 2015 Oct 15 (Print Publication: 2015).
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Medication Adherence*/statistics & numerical data
Anti-Retroviral Agents/*therapeutic use
CD4-Positive T-Lymphocytes/*pathology
HIV Infections/*diagnosis
HIV Infections/*drug therapy
Adult ; CD4 Lymphocyte Count ; Cross-Sectional Studies ; Female ; HIV Infections/blood ; HIV Infections/epidemiology ; HIV-1 ; Humans ; Male ; Middle Aged ; Netherlands/epidemiology ; Prognosis ; Viral Load
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
ABX464: a good drug candidate instead of a magic bullet.
Autorzy:
Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands. b.berkhout@amc.uva.nl.
van der Velden YU; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
Retrovirology [Retrovirology] 2015 Jul 28; Vol. 12, pp. 64. Date of Electronic Publication: 2015 Jul 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Viral Load*
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
HIV Infections/*virology
HIV-1/*isolation & purification
Animals ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Bone Marrow Gene Therapy for HIV/AIDS.
Autorzy:
Herrera-Carrillo E; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands. .
Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands. b.berkhout@amc.uva.nl.
Pokaż więcej
Źródło:
Viruses [Viruses] 2015 Jul 17; Vol. 7 (7), pp. 3910-36. Date of Electronic Publication: 2015 Jul 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Genetic Therapy*
Acquired Immunodeficiency Syndrome/*therapy
Bone Marrow/*metabolism
HIV Infections/*therapy
Acquired Immunodeficiency Syndrome/genetics ; Acquired Immunodeficiency Syndrome/virology ; Animals ; HIV Infections/genetics ; HIV Infections/virology ; HIV-1/physiology ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
High prevalence of hepatitis B virus dual infection with genotypes A and G in HIV-1 infected men in Amsterdam, the Netherlands, during 2000-2011.
Autorzy:
van der Kuyl AC; Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Meibergdreef 15, Amsterdam 1105, AZ, Netherlands. .
Zorgdrager F
Hogema B
Bakker M
Jurriaans S
Back NK
Berkhout B
Zaaijer HL
Cornelissen M
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2013 Nov 14; Vol. 13, pp. 540. Date of Electronic Publication: 2013 Nov 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections/*virology
HIV-1/*isolation & purification
Hepatitis B/*virology
Hepatitis B virus/*isolation & purification
Coinfection ; DNA, Viral/blood ; DNA, Viral/genetics ; Genotype ; HIV Infections/epidemiology ; Hepatitis B/epidemiology ; Hepatitis B virus/classification ; Hepatitis B virus/genetics ; Humans ; Male ; Netherlands/epidemiology ; Prevalence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Translational HIV-1 research: from routine diagnostics to new virology insights in Amsterdam, the Netherlands during 1983-2013.
Autorzy:
van der Kuyl AC; Laboratory of Experimental Virology, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands. .
Bakker M
Jurriaans S
Back NK
Pasternak AO
Cornelissen M
Berkhout B
Pokaż więcej
Źródło:
Retrovirology [Retrovirology] 2013 Aug 28; Vol. 10, pp. 93. Date of Electronic Publication: 2013 Aug 28.
Typ publikacji:
Historical Article; Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Diagnostic Tests, Routine/*methods
HIV Infections/*diagnosis
HIV Infections/*virology
HIV-1/*isolation & purification
Translational Research, Biomedical/*history
Translational Research, Biomedical/*trends
Viral Load/*methods
Diagnostic Tests, Routine/history ; Diagnostic Tests, Routine/trends ; Evolution, Molecular ; Genome, Viral ; HIV-1/classification ; HIV-1/genetics ; History, 20th Century ; History, 21st Century ; Humans ; Netherlands ; Viral Load/history ; Viral Load/trends
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein Trimers.
Autorzy:
Bontjer I; Department of Medical Microbiology, Laboratory of Experimental Virology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands.
Melchers M
Tong T
van Montfort T
Eggink D
Montefiori D
Olson WC
Moore JP
Binley JM
Berkhout B
Sanders RW
Pokaż więcej
Źródło:
PloS one [PLoS One] 2013 Jun 26; Vol. 8 (6), pp. e67484. Date of Electronic Publication: 2013 Jun 26 (Print Publication: 2013).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
AIDS Vaccines/*administration & dosage
Antibodies, Neutralizing/*immunology
Antibody Formation/*immunology
HIV Antibodies/*immunology
HIV Infections/*prevention & control
HIV-1/*immunology
env Gene Products, Human Immunodeficiency Virus/*immunology
AIDS Vaccines/immunology ; Animals ; Antibodies, Neutralizing/blood ; Epitopes/immunology ; HIV Antibodies/blood ; HIV Infections/immunology ; HIV Infections/virology ; Humans ; Neutralization Tests ; Rabbits ; Sequence Deletion ; env Gene Products, Human Immunodeficiency Virus/chemistry ; env Gene Products, Human Immunodeficiency Virus/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Has the rate of CD4 cell count decline before initiation of antiretroviral therapy changed over the course of the Dutch HIV epidemic among MSM?
Autorzy:
Gras L; Stichting HIV Monitoring, Amsterdam, The Netherlands. />Geskus RB
Jurriaans S
Bakker M
van Sighem A
Bezemer D
Fraser C
Prins JM
Berkhout B
de Wolf F
Pokaż więcej
Corporate Authors:
ATHENA National Observational Cohort
Źródło:
PloS one [PLoS One] 2013 May 27; Vol. 8 (5), pp. e64437. Date of Electronic Publication: 2013 May 27 (Print Publication: 2013).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
CD4 Lymphocyte Count*
HIV Infections/*epidemiology
HIV Infections/*immunology
Adult ; Antiretroviral Therapy, Highly Active ; HIV Infections/drug therapy ; Homosexuality, Male ; Humans ; Male ; Netherlands/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 101

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies